The store will not work correctly when cookies are disabled.
5-(3,6-Diazabicyclo[3.1.1]heptane-3-yl)-N-(2,4-difluorophenyl)nicotinamide
ID: ALA4556523
PubChem CID: 155556961
Max Phase: Preclinical
Molecular Formula: C17H16F2N4O
Molecular Weight: 330.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(F)cc1F)c1cncc(N2CC3CC(C2)N3)c1
Standard InChI: InChI=1S/C17H16F2N4O/c18-11-1-2-16(15(19)4-11)22-17(24)10-3-14(7-20-6-10)23-8-12-5-13(9-23)21-12/h1-4,6-7,12-13,21H,5,8-9H2,(H,22,24)
Standard InChI Key: WHRKMMNRCVIVON-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
17.0189 -9.3493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3935 -9.1259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4734 -9.4520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0714 -8.7327 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7415 -8.9562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6169 -8.6256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6491 -9.8808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4977 -10.6848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1269 -11.2159 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.9026 -10.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0448 -10.1271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4187 -9.5952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5003 -10.3611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8208 -9.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4517 -10.3787 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9661 -9.0346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2276 -10.0983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8548 -10.6318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6302 -10.3520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7760 -9.5390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1403 -9.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3672 -9.2890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7079 -11.4419 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.5526 -9.2574 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 1 1 0
1 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 13 1 0
5 13 1 0
11 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
18 23 1 0
20 24 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.34 | Molecular Weight (Monoisotopic): 330.1292 | AlogP: 2.16 | #Rotatable Bonds: 3 |
Polar Surface Area: 57.26 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.12 | CX LogP: 1.71 | CX LogD: 0.00 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.91 | Np Likeness Score: -1.70 |
References
1. Murineddu G, Gotti C, Asproni B, Corona P, Martinello K, Plutino S, Fucile S, Temml V, Moretti M, Viani P, Schuster D, Piras S, Deligia F, Pinna GA.. (2019) Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors., 180 [PMID:31299587] [10.1016/j.ejmech.2019.06.079] |